ARCHIVES

BioSeek Awarded NIH SBIR For Compound Validation.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

May 31, 1996

Resource Offered for DNA Probe Mapping

August 14, 1987

NCI Cooperative Group Clinical Trials Approved

October 30, 2009

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999